SCHIZOAFFECTIVE DISORDER
Clinical trials for SCHIZOAFFECTIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new SCHIZOAFFECTIVE DISORDER trials appear
Sign up with your email to follow new studies for SCHIZOAFFECTIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart risk check for schizophrenia drugs
Disease control TerminatedThis study aimed to see how two antipsychotic drugs, aripiprazole and ziprasidone, affect heart risk in people with schizophrenia, schizoaffective disorder, or bipolar disorder. Researchers measured blood fats and heart electrical changes in 48 adults over 12 months. The trial wa…
Matched conditions: SCHIZOAFFECTIVE DISORDER
Phase: PHASE3 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 23, 2026 11:56 UTC
-
Eye test may predict schizophrenia drug success
Symptom relief TerminatedThis study aimed to see if a simple eye scan could predict which people with early schizophrenia would benefit from a drug called sodium nitroprusside. The drug was given to reduce psychosis symptoms like delusions and hallucinations. Only one person enrolled before the study was…
Matched conditions: SCHIZOAFFECTIVE DISORDER
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Symptom relief
Last updated Jun 18, 2026 11:57 UTC
-
Can a gentle brain zap quiet the voices? early trial stopped short.
Symptom relief TerminatedThis study tested a noninvasive brain stimulation technique called Auditory Control Enhancement (ACE) to see if it could help people with schizophrenia who still hear voices despite medication. Twelve participants received either real or fake (sham) stimulation during cognitive t…
Matched conditions: SCHIZOAFFECTIVE DISORDER
Phase: NA • Sponsor: Brian A Coffman, PhD • Aim: Symptom relief
Last updated Jun 18, 2026 11:49 UTC
-
Brain zapping study targets smoking in schizophrenia
Knowledge-focused TerminatedThis study tested whether a non-invasive brain stimulation technique called deep rTMS could change brain activity and reduce smoking in people with schizophrenia. Researchers used brain scans to measure changes in brain connections and smoking behavior. The study was small and en…
Matched conditions: SCHIZOAFFECTIVE DISORDER
Phase: NA • Sponsor: Stony Brook University • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:07 UTC
-
Digital therapy tool tested for young people with psychosis
Knowledge-focused TerminatedThis study looked at how well a digital program called Horyzons works in clinics for young people (ages 16-35) with early psychosis. Researchers wanted to understand what helps or hinders using this online tool in real-world care. The study was stopped early, and it focused on ga…
Matched conditions: SCHIZOAFFECTIVE DISORDER
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated Jun 18, 2026 11:51 UTC
-
Can a simple quiz improve lithium safety in hospitals?
Knowledge-focused TerminatedThis study tested a French version of a questionnaire that measures how much patients know about lithium, a medication for bipolar and schizo-affective disorders. About 22 hospitalized adults completed the questionnaire twice, and their scores were compared to their blood lithium…
Matched conditions: SCHIZOAFFECTIVE DISORDER
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:05 UTC